Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles

Leishmaniasis is a disease caused by parasites of Leishmania sp., which effects nearly 12 million people worldwide and is associated with treatment complications due to widespread parasite resistance toward pathogen-directed therapeutics. The current treatments for visceral leishmaniasis (VL), the s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Pharm
Hoofdauteurs: Collier, M.A., Peine, K.J., Gautam, S., Oghumu, S., Varikuti, S., Borteh, H., Papenfuss, T.L., Sataoskar, A.R., Bachelder, E.M., Ainslie, K.M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5730989/
https://ncbi.nlm.nih.gov/pubmed/26768723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2016.01.004
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items